
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ICL_L | 35 | 55.6% | 2.85 | 252 | 85.1% |
| SCL_L | 9 | 14.3% | 1.15 | 20 | 6.8% |
| SPS_L | 1 | 1.6% | 4.52 | 23 | 7.8% |
| SPS_R | 14 | 22.2% | -3.81 | 1 | 0.3% |
| IB_L | 3 | 4.8% | -inf | 0 | 0.0% |
| IB_R | 1 | 1.6% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns CB2665 | % In | CV |
|---|---|---|---|---|---|
| CB2665 (R) | 1 | Glu | 5 | 8.6% | 0.0 |
| PS083b (L) | 2 | Unk | 5 | 8.6% | 0.2 |
| CL064 (L) | 1 | GABA | 4 | 6.9% | 0.0 |
| CL012 (R) | 1 | ACh | 4 | 6.9% | 0.0 |
| PS096 (L) | 4 | GABA | 4 | 6.9% | 0.0 |
| CL107 (L) | 1 | Unk | 3 | 5.2% | 0.0 |
| PS197,PS198 (L) | 2 | ACh | 3 | 5.2% | 0.3 |
| CB1410 (L) | 1 | ACh | 2 | 3.4% | 0.0 |
| cL02a (R) | 1 | GABA | 2 | 3.4% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 2 | 3.4% | 0.0 |
| PS196a (L) | 1 | ACh | 2 | 3.4% | 0.0 |
| SMP048 (R) | 1 | ACh | 2 | 3.4% | 0.0 |
| CL014 (L) | 1 | Glu | 2 | 3.4% | 0.0 |
| PS096 (R) | 2 | GABA | 2 | 3.4% | 0.0 |
| CL340 (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| CL075a (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| CL161b (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| CB1893 (R) | 1 | Glu | 1 | 1.7% | 0.0 |
| LT76 (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| CL316 (R) | 1 | GABA | 1 | 1.7% | 0.0 |
| cM01b (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| ATL040 (L) | 1 | Glu | 1 | 1.7% | 0.0 |
| CL012 (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| CL013 (L) | 1 | Glu | 1 | 1.7% | 0.0 |
| PLP115_b (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| SMP048 (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| SMP393b (L) | 1 | ACh | 1 | 1.7% | 0.0 |
| aMe15 (R) | 1 | ACh | 1 | 1.7% | 0.0 |
| CL239 (L) | 1 | Glu | 1 | 1.7% | 0.0 |
| PS062 (R) | 1 | ACh | 1 | 1.7% | 0.0 |
| downstream partner | # | NT | conns CB2665 | % Out | CV |
|---|---|---|---|---|---|
| CL014 (L) | 3 | Glu | 17 | 22.4% | 0.2 |
| PS158 (L) | 1 | ACh | 9 | 11.8% | 0.0 |
| CL013 (L) | 2 | Glu | 8 | 10.5% | 0.5 |
| CB2665 (R) | 1 | Glu | 5 | 6.6% | 0.0 |
| CL161a (L) | 1 | ACh | 2 | 2.6% | 0.0 |
| CL048 (L) | 1 | Glu | 2 | 2.6% | 0.0 |
| CL245 (L) | 1 | Glu | 2 | 2.6% | 0.0 |
| CL287 (L) | 1 | GABA | 2 | 2.6% | 0.0 |
| CL180 (L) | 1 | Glu | 2 | 2.6% | 0.0 |
| CB1648 (L) | 2 | Glu | 2 | 2.6% | 0.0 |
| CL075a (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB2074 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| CB1451 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| CL086_e (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB3862 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CL005 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB1790 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| SMPp&v1B_M01 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| CB0431 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| PLP032 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB2485 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| PVLP103 (L) | 1 | GABA | 1 | 1.3% | 0.0 |
| CL130 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB1353 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| PLP128 (R) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB1225 (R) | 1 | ACh | 1 | 1.3% | 0.0 |
| CL090_a (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| SMP381 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB1225 (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CL152 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| SMP393b (L) | 1 | ACh | 1 | 1.3% | 0.0 |
| CB2931 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| IB117 (L) | 1 | Glu | 1 | 1.3% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 1.3% | 0.0 |
| CL182 (L) | 1 | Glu | 1 | 1.3% | 0.0 |